| Year |
Citation |
Score |
| 2016 |
Shajani-Yi Z, Lee HK, Cervinski MA. Hyponatremia, Hypokalemia, Hypochloremia, and Other Abnormalities. Clinical Chemistry. 62: 898. PMID 27235468 DOI: 10.1373/clinchem.2015.249292 |
0.44 |
|
| 2016 |
Cembrowski GS, Cervinski MA. Demystifying Reference Sample Quality Control. Clinical Chemistry. PMID 27197680 DOI: 10.1373/clinchem.2016.258129 |
0.44 |
|
| 2015 |
Tolan NV, Parnas ML, Baudhuin LM, Cervinski MA, Chan AS, Holmes DT, Horowitz G, Klee EW, Kumar RB, Master SR. "Big Data" in Laboratory Medicine. Clinical Chemistry. PMID 26487761 DOI: 10.1373/clinchem.2015.248591 |
0.44 |
|
| 2015 |
Cervinski MA, Lee HK, Martin IW, Gavrilov DK. A macro-enzyme cause of an isolated increase of alkaline phosphatase. Clinica Chimica Acta; International Journal of Clinical Chemistry. 440: 169-71. PMID 25463746 DOI: 10.1016/j.cca.2014.11.017 |
0.44 |
|
| 2014 |
Burchard PR, Abou Tayoun AN, Lefferts JA, Lewis LD, Tsongalis GJ, Cervinski MA. Development of a rapid clinical TPMT genotyping assay. Clinical Biochemistry. 47: 126-9. PMID 25093923 DOI: 10.1016/j.clinbiochem.2014.07.088 |
0.44 |
|
| 2014 |
Kelsey DE, Toher JL, Foster MT, Boulanger JA, Cervinski MA. Laboratory validation of a low density lipoprotein apolipoprotein-B assay. Clinical Biochemistry. 47: 211-5. PMID 25079242 DOI: 10.1016/j.clinbiochem.2014.07.016 |
0.44 |
|
| 2014 |
Cervinski MA. Laboratory analysis of intraosseous blood: bad to the bone? Clinical Chemistry and Laboratory Medicine. 52: e187-9. PMID 24636999 DOI: 10.1515/cclm-2014-0104 |
0.44 |
|
| 2014 |
Cervinski MA, Sam SS, Steinmetz HB, Wood B, Tsongalis GJ. Validation of interleukin 28B genotyping assay for clinical use. Clinical Biochemistry. 47: 478-80. PMID 24462832 DOI: 10.1016/j.clinbiochem.2014.01.009 |
0.44 |
|
| 2013 |
McCudden CR, Cervinski MA, Grenache DG, Haymond S, Korpi-Steiner N, Molinaro RJ, Saenger AK. The SYCL toolkit: creating a program within a professional organization for young scientists. Clinical Chemistry. 59: 1416-7. PMID 24137752 DOI: 10.1373/clinchem.2013.211011 |
0.44 |
|
| 2013 |
Cervinski MA, Schwab MC, Lefferts JA, Lewis LD, Lebel KA, Tyropolis AM, Pflueger SM, Tsongalis GJ. Establishment of a CYP2C19 genotyping assay for clinical use. American Journal of Clinical Pathology. 139: 202-7. PMID 23355205 DOI: 10.1309/AJCP9K2KDOCPCBSV |
0.44 |
|
| 2012 |
Feix MK, Polito FA, Cervinski MA. A urine sample with an orange to red hue, what should we do? Clinical Chemistry. 58: 1497-8. PMID 23024130 DOI: 10.1373/clinchem.2012.187864 |
0.44 |
|
| 2010 |
Crimmins DL, Brada NA, Lockwood CM, Griest TA, Waldemer RJ, Cervinski MA, Ohlendorf MF, McQuillan JJ, Ladenson JH. ETRAP (efficient trapping and purification) of target protein polyclonal antibodies from GST-protein immune sera. Biotechnology and Applied Biochemistry. 57: 127-38. PMID 21054278 DOI: 10.1042/BA20100279 |
0.44 |
|
| 2010 |
Cervinski MA, Foster JD, Vaughan RA. Syntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression. Neuroscience. 170: 408-16. PMID 20643191 DOI: 10.1016/j.neuroscience.2010.07.025 |
0.44 |
|
| 2010 |
Bender L, Silverman LM, Dinulos MB, Nickel J, Grody WW. Direct-to-consumer genotyping: are we ready for a brave new world? Clinical Chemistry. 56: 1056-60. PMID 20511451 DOI: 10.1373/clinchem.2009.138743 |
0.44 |
|
| 2010 |
Cervinski MA, Gronowski AM. Reproductive-endocrine point-of-care testing: current status and limitations. Clinical Chemistry and Laboratory Medicine. 48: 935-42. PMID 20446758 DOI: 10.1515/CCLM.2010.183 |
0.44 |
|
| 2009 |
Cervinski MA, Lockwood CM, Ferguson AM, Odem RR, Stenman UH, Alfthan H, Grenache DG, Gronowski AM. Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy. Clinica Chimica Acta; International Journal of Clinical Chemistry. 406: 81-5. PMID 19477170 DOI: 10.1016/j.cca.2009.05.018 |
0.44 |
|
| 2009 |
Gronowski AM, Cervinski M, Stenman UH, Woodworth A, Ashby L, Scott MG. False-negative results in point-of-care qualitative human chorionic gonadotropin (hCG) devices due to excess hCGbeta core fragment. Clinical Chemistry. 55: 1389-94. PMID 19395437 DOI: 10.1373/clinchem.2008.121210 |
0.44 |
|
| 2009 |
Cervinski MA, Duh SH, Hock KG, Gray J, Wei TQ, Kilgore DC, Christenson RH, Scott MG. Performance characteristics of a no-pretreatment, random access sirolimus assay for the Dimension RxL clinical chemistry system. Clinical Biochemistry. 42: 1123-7. PMID 19303402 DOI: 10.1016/j.clinbiochem.2009.03.009 |
0.44 |
|
| 2006 |
Foster JD, Cervinski MA, Gorentla BK, Vaughan RA. Regulation of the dopamine transporter by phosphorylation. Handbook of Experimental Pharmacology. 197-214. PMID 16722237 DOI: 10.1007/3-540-29784-7-10 |
0.44 |
|
| 2005 |
Cervinski MA, Foster JD, Vaughan RA. Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms. The Journal of Biological Chemistry. 280: 40442-9. PMID 16204245 DOI: 10.1074/jbc.M501969200 |
0.44 |
|
| 2003 |
Foster JD, Pananusorn B, Cervinski MA, Holden HE, Vaughan RA. Dopamine transporters are dephosphorylated in striatal homogenates and in vitro by protein phosphatase 1. Brain Research. Molecular Brain Research. 110: 100-8. PMID 12573538 DOI: 10.1016/S0169-328X(02)00645-9 |
0.44 |
|
| Show low-probability matches. |